Skip to main content
. 2022 Jan 5;21(4):416–426. doi: 10.1080/15384101.2021.2020962

Figure 3.

Figure 3.

FRRS1 enhances the proliferation of cervical cancer cells Notes: After the SiHa cells and Hela cells were transfected with sh-FRRS1 or co-transfected with sh-FRRS1+ pCDNA3.1-HOXD-AS1, (a-b) qRT-PCR and Western blotting measured the expression of FRRS1; (c) CCK-8 detected the cell vitality; (d) EDU staining assessed the proliferative ability of the cervical cancer cells; (e) flow cytometry assessed the apoptosis rate. Data are presented as mean ± SD (standard deviation).  **P < 0.01, ***P < 0.001; CESC, cervical squamous cell carcinoma.